Patents by Inventor Christophe Folly

Christophe Folly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11396669
    Abstract: The invention relates to recombinant microorganisms and methods for producing steviol glycosides and steviol glycoside precursors.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: July 26, 2022
    Assignee: Evolva SA
    Inventors: Jon Heal, Philipp Berninger, Kim Olsson, Joe Sheridan, Laura Occhipinti, Laura Brembati, Christian Nyffenegger, Christophe Folly
  • Patent number: 11299717
    Abstract: The invention relates to recombinant microorganisms and methods of producing citronellal, citronellol, citronellic acid, and/or citronellal/citronellol pathway intermediates and precursors.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: April 12, 2022
    Inventors: Thomas Oestergaard Tange, Johannes Haerle, Fanny Delegrange, Julien Denis Vivian De Block, Robert Charles Allan, Philipp Friedrich Berninger, Christophe Folly, Davide Antonio Ravasio, Ludivine Labagnere, Federico Brianza, Curt Aimé Friis Nielsen, Jørgen Hansen, Nora Weber, Samantha Jessica Capewell
  • Publication number: 20200080123
    Abstract: The invention relates to recombinant microorganisms and methods for producing steviol glycosides and steviol glycoside precursors.
    Type: Application
    Filed: November 7, 2017
    Publication date: March 12, 2020
    Inventors: Jon Heal, Philipp Berninger, Kim Olsson, Joe Sheridan, Laura Occhipinti, Laura Brembati, Christian Nyffenegger, Christophe Folly
  • Publication number: 20190225945
    Abstract: The invention relates to recombinant microorganisms and methods of producing citronellal, citronellol, citronellic acid, and/or citronellal/citronellol pathway intermediates and precursors.
    Type: Application
    Filed: October 11, 2017
    Publication date: July 25, 2019
    Inventors: Thomas Oestergaard Tange, Johannes Haerle, Fanny Delegrange, Julien Denis Vivian De Block, Robert Charles Allan, Philipp Friedrich Berninger, Christophe Folly, Davide Antonio Ravasio, Ludivine Labagnere, Federico Brianza, Curt Aimé Friis Nielsen, Jørgen Hansen, Nora Weber, Samantha Jessica Capewell
  • Patent number: 10190140
    Abstract: This invention provides recombinant cells and methods for producing terpenes and terpenoids by increasing production or accumulation or both of isoprenoid precursors thereof.
    Type: Grant
    Filed: August 1, 2017
    Date of Patent: January 29, 2019
    Assignee: EVOLVA SA
    Inventors: Thomas Oestergaard Tange, Michael Naesby, Christophe Folly, Fanny Delegrange, Jens Houghton-Larsen, Simon Carlsen
  • Publication number: 20180080054
    Abstract: This invention provides recombinant cells and methods for producing terpenes and terpenoids by increasing production or accumulation or both of isoprenoid precursors thereof.
    Type: Application
    Filed: August 1, 2017
    Publication date: March 22, 2018
    Inventors: Thomas M. Ostergaard Tange, Michael Naesby, Christophe Folly, Fanny Delegrange, Jens Houghton-Larsen, Simon Carlsen
  • Patent number: 9834800
    Abstract: This invention provides recombinant cells and methods for producing terpenes and terpenoids by increasing production or accumulation or both of isoprenoid precursors thereof.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: December 5, 2017
    Assignee: Evolva SA
    Inventors: Thomas Oestergaard Tange, Michael Naesby, Christophe Folly, Fanny Delegrange, Jens Houghton-Larsen, Simon Carlsen
  • Patent number: 9828617
    Abstract: Microorganisms and processes for the recombinant manufacture of clavine-type alkaloids such as cycloclavine, festuclavine, agroclavine, chanoclavine and chanoclavine aldehyde, as well as polypeptides, polynucleotides and vectors comprising such polynucleotides which can be applied in a method for the manufacture of clavine-type alkaloids are provided.
    Type: Grant
    Filed: August 13, 2013
    Date of Patent: November 28, 2017
    Assignees: BASF SE, Evolva SA
    Inventors: Michael Naesby, Christophe Folly, Curt Aimé Friis Nielsen, Anaelle Hatsch, Markus Schwab, Oskar Zelder, Stefan Haefner, Hartwig Schroeder, Birgit Hoff, Andrea Molt, Klaus Ditrich, Michael Breuer, Holger Hartmann, Karsten Koerber
  • Publication number: 20150225754
    Abstract: This invention provides recombinant cells and methods for producing terpenes and terpenoids by increasing production or accumulation or both of isoprenoid precursors thereof.
    Type: Application
    Filed: August 19, 2013
    Publication date: August 13, 2015
    Inventors: Thomas Oestergaard Tange, Michael Naesby, Christophe Folly, Fanny Delegrange, Jens Houghton-Larsen, Simon Carlsen
  • Publication number: 20150211036
    Abstract: Microorganisms and processes for the recombinant manufacture of clavine-type alkaloids such as cycloclavine, festuclavine, agroclavine, chanoclavine and chanoclavine aldehyde, as well as polypeptides, polynucleotides and vectors comprising such polynucleotides which can be applied in a method for the manufacture of clavine-type alkaloids are provided.
    Type: Application
    Filed: August 13, 2013
    Publication date: July 30, 2015
    Applicants: BASF SE, Evolva SA
    Inventors: Michael Naesby, Christophe Folly, Curt Aimé Friis Nielsen, Anaelle Hatsch, Markus Schwab, Oskar Zelder, Stefan Haefner, Hartwig Schroeder, Birgit Hoff, Andrea Molt, Klaus Ditrich, Michael Breuer, Holger Hartmann, Karsten Koerber